Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | TWST | TVTX | ||
| Company | Apellis Pharmaceuticals Inc | Twist Bioscience Corp | Travere Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 41.05 | 87.75 | 56.39 | ||
| High | 41.07 | 91.92 | 57.83 | ||
| Low | 41.03 | 86.50 | 55.56 | ||
| Last | 41.03 | 91.33 | 57.28 | ||
| Change | -0.03 | +5.86 | +1.72 | ||
| Percent Change | -0.07% | +6.86% | +3.10% | ||
| Volume | 68,611,400 | 1,656,800 | 1,014,800 | ||
| 20-Day Average Volume | 7,541,190 | 1,361,630 | 1,257,535 | ||
| Previous | 41.06 | 85.47 | 55.56 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 40.97 | 91.83 | 56.78 | ||
| 20-Day Raw Stochastic | 67.65% | 37.63% | 61.14% | ||
| 20-Day Relative Strength | 81.66 | 54.67 | 59.13 | ||
| Weighted Alpha | +25.64 | +200.81 | +173.88 | ||
| Today's Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Yesterday's Opinion | 100% Buy | 80% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.22% since 05/06/26 | -1.20% since 07/23/26 | +1.06% since 07/23/26 | ||
| Low | 40.98 on 05/07/26 | 82.80 on 07/29/26 | 54.59 on 07/29/26 | ||
| High | 41.08 on 05/12/26 | 95.31 on 07/27/26 | 59.09 on 07/27/26 | ||
| 1-Month | |||||
| %Chg | +0.47% since 04/13/26 | -11.23% since 06/30/26 | +0.83% since 06/30/26 | ||
| Low | 40.78 on 04/14/26 | 82.80 on 07/29/26 | 53.00 on 07/17/26 | ||
| High | 41.14 on 05/06/26 | 105.47 on 07/02/26 | 60.00 on 07/23/26 | ||
| 3-Month | |||||
| %Chg | +89.08% since 02/13/26 | +56.25% since 04/30/26 | +35.99% since 04/30/26 | ||
| Low | 16.83 on 03/30/26 | 48.00 on 05/15/26 | 41.32 on 05/19/26 | ||
| High | 41.14 on 05/06/26 | 105.47 on 07/02/26 | 60.10 on 06/25/26 | ||
| 6-Month | |||||
| %Chg | +107.12% since 11/13/25 | +122.38% since 01/30/26 | +84.24% since 01/30/26 | ||
| Low | 16.83 on 03/30/26 | 41.52 on 03/20/26 | 26.15 on 03/20/26 | ||
| High | 41.14 on 05/06/26 | 105.47 on 07/02/26 | 60.10 on 06/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,252,701 | 5,322,301 | 5,166,691 | ||
| Shares Outstanding, K | 128,021 | 62,271 | 92,993 | ||
| Annual Sales, $M | 1,003,780,000 | 376,570,000 | 490,730,000 | ||
| Annual Net Income, $M | 22,390,000 | -77,670,000 | -25,550,000 | ||
| Last Qtr Sales, $M | 268,300,000 | 110,720,000 | 127,200,000 | ||
| Last Qtr Income, $M | 18,660,000 | -44,020,000 | -37,100,000 | ||
| 60-Month Beta | -0.24 | 2.11 | 1.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.15 on 05/07/26 | -0.62 on 05/04/26 | -0.39 on 05/04/26 | ||
| Latest Earnings Date | 07/30/26 | 08/03/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 40.25 | 0.00 | 0.00 | ||